Filtered By:
Specialty: Internal Medicine
Source: Annals of Internal Medicine
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 404 results found since Jan 2013.
In acute stroke with a large ischemic region, endovascular therapy improved functional status at 90 d
Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0035. Online ahead of print.ABSTRACTYoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med. 2022;386:1303-13. 35138767.PMID:35667074 | DOI:10.7326/J22-0035
Source: Annals of Internal Medicine - June 6, 2022 Category: Internal Medicine Authors: Bruce M Lo Christopher R Carpenter Source Type: research
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study
CONCLUSION: As first-line T2D treatment, initiators receiving SGLT-2i showed a similar risk for MI/stroke/mortality, lower risk for HHF/mortality and HHF, and a similar safety profile except for an increased risk for genital infections compared with those receiving metformin.PRIMARY FUNDING SOURCE: Brigham and Women's Hospital and Harvard Medical School.PMID:35605236 | DOI:10.7326/M21-4012
Source: Annals of Internal Medicine - May 23, 2022 Category: Internal Medicine Authors: HoJin Shin Sebastian Schneeweiss Robert J Glynn Elisabetta Patorno Source Type: research
In older persons at risk for dementia, a multidomain approach reduced stroke and transient ischemic attack
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0030. Online ahead of print.ABSTRACTLehtisalo J, Rusanen M, Solomon A, et al. Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial. Eur Heart J. 2022. [Epub ahead of print.] 35051281.PMID:35500268 | DOI:10.7326/J22-0030
Source: Annals of Internal Medicine - May 2, 2022 Category: Internal Medicine Authors: Konstantin A Krychtiuk Christopher B Granger Source Type: research
Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study
CONCLUSION: From 2000 to 2018, the use of PDE5 inhibitors increased 20-fold among Danish patients with IHD who were taking nitrates. A statistically significant association between concomitant use of these medications and cardiovascular adverse events could not be identified.PRIMARY FUNDING SOURCE: Ib Mogens Kristiansens Almene Fond and Helsefonden.PMID:35436155 | DOI:10.7326/M21-3445
Source: Annals of Internal Medicine - April 18, 2022 Category: Internal Medicine Authors: Anders Holt Paul Blanche Aksel Karl Georg Jensen Nina Nouhravesh Deepthi Rajan Mads Hashiba Jensen Mohammed El-Sheikh Anne-Marie Schjerning Morten Schou Gunnar Gislason Christian Torp-Pedersen Patricia McGettigan Morten Lamberts Source Type: research
